Skip to content
Screener

Aehr Test Systems AEHR Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Amkor Technology logo
Amkor TechnologyAMKR
UCT
Ultra Clean HoldingsUCTT
Ralliant Corp logo
Ralliant CorpRAL
SKY
SKYTSKYT

Other financials

Income statement

See full
Revenue$10.3M-43.7%
Gross profit$3.4M-53.1%
Operating income-$4.2M-278%
Net income-$3.2M-398%
EPS (diluted)-$0.10-400%

Balance sheet

See full
Cash & equivalents$116.4M+339%
Total debt$9.9M-8.8%
Total equity$219.5M+78.7%
Total assets$246.7M+66.1%

Cash flow

See full
Operating cash flow-$5.1M-0.9%
CapEx$1.9M-11.1%
Free cash flow-$7.1M+2.7%

Valuation

See full
Market cap$3.46B+562%
Enterprise value$3.36B+562%
P/S68×+59.4×

Profitability

See full
Gross margin39.5%-8.0pp
Operating margin14.3%+0.7pp
Net margin44.2%+27.4pp
FCF margin-27.1%

Returns & leverage

See full
Return on equity32.3%+20.3pp
Debt / equity0.0×
Current ratio10.3×+4.7×

Where this comes from

Reported directly by Aehr Test Systems in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The source filing: Aehr Test Systems’s 10-Q, filed April 8, 2026.

Filed
Apr 8, 2026, 4:05 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001654954-26-003348
(In thousands, except par value)February 27, 2026May 30, 2025
Total liabilities18,25425,637
Commitments and contingencies (Note 6)
Shareholders’ equity:
Preferred stock, $0.01 par value: Authorized: 10,000 shares;
Issued and outstanding: none--
Common stock, $0.01 par value: Authorized: 75,000 shares;
Issued and outstanding: 30,954 shares and 29,877 shares at February 27, 2026 and May 30, 2025, respectively310299
Additional paid-in capital170,143145,758

Item 1. Financial Statements (unaudited)

FAQ

What is Aehr Test Systems's preferred stock, shares authorized?
Aehr Test Systems (AEHR) reported preferred stock, shares authorized of $10M in Q1 2026.
How has Aehr Test Systems's preferred stock, shares authorized changed year-over-year?
Aehr Test Systems's preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
What is the long-term trend for Aehr Test Systems's preferred stock, shares authorized?
Over 2 years (2023 to 2025), Aehr Test Systems's preferred stock, shares authorized has grown at a 3062.3% compound annual growth rate (CAGR), from $10K to $10M.

Ask your AI about Aehr Test Systems's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude